Clinical Trials Directory

Trials / Completed

CompletedNCT05580783

Iron Absorption and Variations of Iron Status, Hepcidin, Inflammation and Sex Hormones During the Menstrual Cycle

Iron Absorption and Variations of Iron Status Parameters, Hepcidin, Inflammatory Markers and Sex Hormones During the Menstrual Cycle

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Isabelle Herter-Aeberli · Academic / Other
Sex
Female
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Iron supplementation is the first line of treatment of iron deficiency in most women, but we do not know when the best time is to supplement in the context of the menstrual cycle. With this study, we aim to measure and compare iron status, hepcidin, inflammatory markers, hormones estrogen and progesterone and changes in iron absorption at various points throughout the menstrual cycle, with a long-term view to determine best time for iron supplementation in relation to the menstrual cycle.

Detailed description

To date, very few studies have assessed iron absorption in relation to a woman's menstrual cycle. Although oral iron supplementation is considered the first line of treatment for iron deficiency in most women, there is no knowledge on the relationship between this intervention in the context of the menstrual cycle, and more specifically there is no knowledge on its potential implications for the most appropriate timing of iron supplementation. A better understanding of iron absorption during the menstrual cycle as well as kinetics of key parameters could allow the design of adapted and/or new interventions (e.g., timing of iron supplementation in relation to different phases of the menstrual cycle) to mitigate iron deficiency in menstruating women and can inform programs aimed at addressing iron deficiency

Conditions

Interventions

TypeNameDescription
OTHERTest meal labelled with 54FeEach participant will receive 2 test meals containing 4mg each of isotopic tracer 54Fe
OTHERTest meal labelled with 57FeEach participant will receive 2 test meals containing 4mg each of isotopic tracer 57Fe
OTHERTest meal labelled with 58FeEach participant will receive 2 test meals containing 4mg each of isotopic tracer 58Fe

Timeline

Start date
2022-11-05
Primary completion
2023-01-06
Completion
2023-05-15
First posted
2022-10-14
Last updated
2023-11-22

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05580783. Inclusion in this directory is not an endorsement.